Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
about
Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in EuropePrisoners co-infected with tuberculosis and HIV: a systematic reviewClinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.HIV, Hepatitis C, TB, Harm Reduction, and Persons Deprived of Liberty: What Standards Does International Human Rights Law Establish?Facilitators and barriers for retention in HIV care between testing and treatment in Asia-A study in Bangladesh, Indonesia, Lao, Nepal, Pakistan, Philippines and VietnamUse of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort studyAssessing Spatial Relationships between Race, Inequality, Crime, and Gonorrhea and Chlamydia in the United States.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A "Seek, Test, Treat, and Retain" Harmonization Consortium.Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.Bringing it all back home: Understanding the medical difficulties encountered by newly released prisoners in New Orleans, Louisiana - a qualitative study.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Integrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control Efforts.Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.Prevalence of HIV in a Prison of Tehran by Active Case Finding.A call for differentiated approaches to delivering HIV services to key populations.Emerging Trends in Epidemiology of Hepatitis B Virus Infection.Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational studyHigh variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany.Predictors of Mortality within Prison and after Release among Persons Living with HIV in Indonesia.Cultural Adaptation of a Medication Adherence Intervention With Prisoners Living With HIV in Indonesia: A Pragmatic Approach to Intervention Development.Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study.Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.[Zika virus infection and the nervous system].Factors associated with HIV prevalence in a prison population.Addressing deprivation of liberty, human mobility and tuberculosis in 2018.Epidemiology and Treatment of Hepatitis B in Prisoners.Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection.Epidemiology of HIV, Sexually Transmitted Infections, Viral Hepatitis, and Tuberculosis Among Incarcerated Transgender People: A Case of Limited Data.Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.HIV and Viral Hepatitis Among Imprisoned Key Populations.Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis.
P2860
Q28069741-0358EFAC-7AD1-446A-84D7-6A7EC7DF4795Q28080180-3CD288E2-3281-45B7-9EF3-B19EEA583B16Q30248944-C66BEC07-CEBA-4F68-9508-CF937852AB2FQ33573897-2164FFB5-1D6F-4EAF-8825-DC220304751BQ33620970-AD77254C-5243-4208-A46C-BE77CEBA183BQ33884145-3D1C16CD-0430-49B5-A29F-A5F0AB4C9CDCQ38613008-7476C940-DBE6-445B-85B1-8284CACB19B3Q38613271-56B14D2A-397F-438E-9525-0D91E026B8ACQ38661825-6D4F114A-3477-4775-9430-28B323EFBF8FQ38753617-189498E7-E136-4B1A-9EA2-C48568EEAD20Q38829492-447066D9-0A20-49A7-A8A8-16B2C6591625Q38931620-F562E484-7957-48B9-8EE9-D7B369884861Q38966480-872BBEFA-1D40-4034-8D67-1DBF00E0327EQ39057197-B5707AA5-D029-4EC2-A019-37EAC226DD3AQ39545462-58CCF4AA-007A-423D-8293-B4E4497B2EBBQ40092669-0D70E08D-24F5-47EF-8F6A-7DB65B618249Q40128070-A29E1C80-99D2-414F-A855-628CB7C30246Q40212094-6D8B0C76-F89F-4039-AED8-A66FE46F3199Q40230760-823386DD-B332-4A21-8F9E-4EA0CD7A8D03Q41570808-720EC587-C0A9-4337-9982-E959E01456A0Q41706861-29D40394-4F41-413A-A420-CDB1DFC38E79Q42625921-72033EB7-9998-4839-8334-7F6166990D50Q42634287-9972DF24-85C6-4D7F-94BC-318DBFB7B5DBQ47159420-07C218F1-498A-4156-AFD7-809D2586E7D6Q47254295-72B6A24A-9DFA-4415-BCEB-AAE65A236A5DQ47389289-291C4E22-E335-4ECF-ABE9-C9E388AC0E20Q47547903-EC5A459C-B7D9-4ECC-98D9-F1FDA86F10EBQ47558002-14182099-5561-4EF0-82D3-2ACF64D94461Q47561936-0D8A2803-D9D1-4582-8181-713DF18C85A1Q47801005-B44AFCD6-DBEB-47C9-A7DC-1011695E871AQ49954474-5F40936D-F888-4FCC-809E-91B5EB353577Q49988168-D0C76291-6054-4A84-AD61-0A8B8E6343CBQ50131423-3F1B3D90-7166-4E2B-AAE3-168481844BA4Q51738481-A6203C69-1111-4936-B55D-01A0917DD21BQ52317642-849F226F-CD4B-4304-B741-68708D314A0FQ52597020-4D1AD5A8-46BC-4C04-95F7-8A1A19E05966Q52642656-50C23EF9-A5F0-4FD1-8857-710DE8D68280Q53403318-DA0639F0-4168-4150-ABFE-4C56844D6DD1Q54214247-3FC4883D-ED77-492A-A0D6-D554A4F68286Q54217920-81A3F8D7-441B-452D-B810-E3EB461054F2
P2860
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
@ast
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
@en
type
label
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
@ast
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
@en
prefLabel
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
@ast
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
@en
P2093
P50
P1433
P1476
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
@en
P2093
Alison Galvani
Andrea L Wirtz
Babak Moazen
Chris Beyrer
Margaret Hellard
Martial Ndeffo-Mbah
Stuart A Kinner
P304
P356
10.1016/S0140-6736(16)30466-4
P407
P577
2016-07-14T00:00:00Z